MedTrace Logo

The China Valvular Heart Disease Study

NCT03484806 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 13917

Last updated 2022-04-13

No results posted yet for this study

Summary

This is a observational、multicenter, prospective cohort study for adults with significant VHD. The purposes of this study were to evaluate the etiology、clinical characteristics、treatment modalities, and outcomes of patients with VHD；also to set up registration system of adult VHD in China, to build a database of Chinese adult VHD, to establish a web-based international standard data acquisition system for VHD and a multicenter clinical research platform. The results of the study will provide a basis for the future national health policy for prevention and treatment of adult VHD.

Conditions

  • Valvular Heart Disease

Sponsors & Collaborators

  • Chinese Academy of Medical Sciences

    collaborator OTHER

  • China National Center for Cardiovascular Diseases

    lead OTHER_GOV

Principal Investigators

  • yongjian wu, doctor · Fuwai Hospital, National Center for Cardiovascular Diseases，Chinese Academy of Medical Sciences

  • haiyan xu, doctor · Fuwai Hospital, National Center for Cardiovascular Diseases，Chinese Academy of Medical Sciences

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-04-01
Primary Completion
2020-09-01
Completion
2020-10-01

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03484806 on ClinicalTrials.gov